Fig. 2From: Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancerCost-effectiveness plane showing results from 5,000 Monte Carlo simulationsBack to article page